Cargando…
Major bleeding events in octagenarians associated with drug interactions between dabigatran and P-gp inhibitors
BACKGROUND: The direct oral anticoagulant dabigatran does not require any routine therapeutic drug monitoring. Yet, concerns about possible drug interactions susceptible to increase its inherent bleeding risk, especially in very elderly patients, have been raised recently. The aim of our study was t...
Autores principales: | Bernier, Marjorie, Lancrerot, Sarah-Line, Rocher, Fanny, Van-Obberghen, Elise K, Olivier, Pierre, Lavrut, Thibaud, Parassol-Girard, Nadège, Drici, Milou-Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Science Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6911799/ https://www.ncbi.nlm.nih.gov/pubmed/31853245 http://dx.doi.org/10.11909/j.issn.1671-5411.2019.11.002 |
Ejemplares similares
-
Case Report: Successful Treatment of Steroid-Refractory Immune Checkpoint Inhibitor-Related Pure Red Cell Aplasia With Cyclosporin
por: Gérard, Alexandre, et al.
Publicado: (2020) -
Are current guidelines adapted for patient eligibility to PrEP? A case report
por: Van Obberghen, Elise K., et al.
Publicado: (2019) -
“Off-label” use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers
por: Gérard, Alexandre, et al.
Publicado: (2020) -
Insights on the Evidence of Cardiotoxicity of Hydroxychloroquine Prior and During COVID‐19 Epidemic
por: Romani, Serena, et al.
Publicado: (2020) -
Calcitonin gene-related peptide-targeting drugs and Raynaud’s phenomenon: a real-world potential safety signal from the WHO pharmacovigilance database
por: Gérard, Alexandre O., et al.
Publicado: (2022)